Korean Society of Gynecologic Oncology spring symposium was successfully finished at Kim Dae Joong Convention Center in Gwang Ju from April 19-20. Specialists from the U.S., France and Japan were invited to this conference and lectured regarding various clinical topics and its basis.

There, Seegene represented a product which can run HPV DNA and STI detection test simultaneously using specimen collected for cervical cancer screening. The most common detection method for cervical cancer is screening, however, as Seegene proprietary technology has developed a molecular diagnostic product which determines both HPV DNA and STI detection with specimens already collected for screening test, many of participants showed their great interests to this product.